AI set to transform digital pathology for hospitals, says Frost & Sullivan
A big shift is coming for digital pathology and artificial intelligence, as focus moves from the pharma sector toward clinical […]
Healthcare technology and services specialist Flatiron Health and the U.S. Food and Drug Administration (FDA) announced a two-year renewal and […] A new clinical practice guideline from the American Academy of Sleep Medicine (AASM) provides guidance to clinicians on the use […] Currently, nearly 30 percent of the members served by Indiana-based health services company Seniorlink have a diagnosis of dementia. THE […] BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization […] San Mateo, Calif, Nov 14, 2018 – Attenua, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to treat […] Body parts scandal deepens as 15 MORE sites in Yorkshire are storing waste illegally after troubled firm stripped of NHS […] TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and […] JERUSALEM–(BUSINESS WIRE)–Jun. 15, 2018– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a change in the clinical development […] By optimizing its EHR's advanced clinical documentation technology for treating rheumatoid arthritis patients, Phoenix Children’s enhanced care and physician productivity […]Clinical
FDA, Flatiron Health expand cancer research partnership
AASM publishes clinical practice guideline on use of PAP therapy for sleep apnea
Care management tech drops hospitalizations and ER visits at Caregiver Homes
Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
15 more units illegally storing clinical waste in body parts scandal
Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018
Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache
How Phoenix Children's structured its EHR to be disease specific to improve care, drive savings